Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) EPS (Basic) (2020 - 2025)

Medicale (MCLE) has disclosed EPS (Basic) for 5 consecutive years, with -$0.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, EPS (Basic) changed N/A year-over-year to -$0.0, compared with a TTM value of -$0.0 through Jun 2025, changed N/A, and an annual FY2023 reading of $0.0, up 118.96% over the prior year.
  • EPS (Basic) was -$0.0 for Q2 2025 at Medicale, up from -$0.0 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.0 in Q4 2022 and bottomed at -$0.01 in Q2 2021.
  • Average EPS (Basic) over 4 years is -$0.0, with a median of -$0.0 recorded in 2025.
  • Peak annual rise in EPS (Basic) hit 175.83% in 2022, while the deepest fall reached 94.4% in 2022.
  • Year by year, EPS (Basic) stood at -$0.0 in 2021, then surged by 175.83% to $0.0 in 2022, then plummeted by 3395.6% to -$0.0 in 2024, then skyrocketed by 76.16% to -$0.0 in 2025.
  • Business Quant data shows EPS (Basic) for MCLE at -$0.0 in Q2 2025, -$0.0 in Q1 2025, and -$0.0 in Q4 2024.